Insider · CIK 0001639647
Adam Woodrow
Files at PRTK (Paratek Pharmaceuticals, Inc.). First filing Nov 1, 2022, latest Dec 22, 2022.
In brief
Adam Woodrow files SEC Form 4 as president at PRTK (Paratek Pharmaceuticals, Inc.). Since Nov 1, 2022, Adam Woodrow has reported 0 open-market buys worth $0 and 3 open-market sells worth $49k, the latest filed on Dec 22, 2022.
A track record needs three past buys with six months of prices behind them; Adam Woodrow has 0, so none is measured yet.
The newest scored trade: sold $13k of PRTK on Dec 21, 2022, filed Dec 22, 2022, scored 15 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Paratek Pharmaceuticals, Inc. | $13k 6,750 shares | -1% | - | |
| 15Weak | Paratek Pharmaceuticals, Inc. | $20k 10,073 shares | -2% | - | |
| 15Weak | Paratek Pharmaceuticals, Inc. | $16k 4,563 shares | -1% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 20, 2022 | PRTK Paratek Pharmaceuticals, Inc. | AGrant or award Common Stock | +22,500 | $0.00 | $0 | 658,034 | Dec 22, 2022 |
| Dec 21, 2022 | PRTK Paratek Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -6,750 | $1.99 | $13k | 651,284 | Dec 22, 2022 |
| Dec 12, 2022 | PRTK Paratek Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -3,820 | $1.98 | $7,564 | 641,787 | Dec 14, 2022 |
| Dec 13, 2022 | PRTK Paratek Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -6,253 | $1.96 | $12k | 635,534 | Dec 14, 2022 |
| Oct 28, 2022 | PRTK Paratek Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -4,563 | $3.47 | $16k | 645,607 | Nov 1, 2022 |
| Oct 25, 2022 | PRTK Paratek Pharmaceuticals, Inc. | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 650,170 | Oct 27, 2022 |
Questions about Adam Woodrow
Answered from the filings on this page, as of the latest one.
Is Adam Woodrow buying or selling?
Not in the last 12 months. Adam Woodrow's latest open-market trade on SEC Form 4 was sold $13k of PRTK on Dec 21, 2022.
How did Adam Woodrow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam Woodrow has 0.
Where does Adam Woodrow file Form 4?
Adam Woodrow has filed Form 4 at PRTK (Paratek Pharmaceuticals, Inc.) as President & Chief Commercial. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.